What is the recommended dose and duration of Macrobid (nitrofurantoin) for treating uncomplicated urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Macrobid Dosing and Duration for Uncomplicated UTI

For uncomplicated urinary tract infections in adults, prescribe Macrobid (nitrofurantoin monohydrate/macrocrystals) 100 mg twice daily for 5 days. 1

Standard Dosing Regimen

  • The Infectious Diseases Society of America (IDSA), American College of Physicians, and European Association of Urology all recommend nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days as first-line therapy for uncomplicated UTIs in women. 1, 2

  • This 5-day regimen achieves clinical cure rates of 88-93% and bacterial cure rates of 81-92%. 1, 2

  • The 5-day course is equivalent in efficacy to trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days, with both achieving approximately 90% clinical cure rates. 1

Alternative Dosing Options

  • For vancomycin-resistant Enterococcus (VRE) UTIs specifically, increase the dose to 100 mg four times daily. 1

  • Nitrofurantoin macrocrystals (not the monohydrate/macrocrystal formulation) can be dosed at 50-100 mg four times daily for 5 days, though this is less convenient than twice-daily Macrobid. 1

Critical Contraindications

  • Do not use nitrofurantoin if early pyelonephritis is suspected—it does not achieve adequate tissue concentrations for upper tract infections. 1

  • Nitrofurantoin is contraindicated when creatinine clearance is <60 mL/min due to inadequate urinary drug concentrations and increased risk of peripheral neuropathy and other toxicities. 2

  • However, one retrospective study found nitrofurantoin remained effective in patients with CrCl 30-60 mL/min (69% eradication rate), though this contradicts guideline recommendations. 3 Follow the guideline contraindication at CrCl <60 mL/min to minimize toxicity risk. 2

Duration Considerations: Why Not 3 Days?

  • While some UK guidelines suggest 3-day courses, the consensus from IDSA, European Society for Microbiology and Infectious Diseases (ESMID), and European Association of Urology is 5 days as the optimal duration. 1

  • A 2023 review found little direct evidence supporting 3-day courses of nitrofurantoin, noting that duration recommendations for other antibiotics cannot be extrapolated to nitrofurantoin. 4

  • Do not extend treatment beyond 7 days unless symptoms persist, as shorter courses minimize adverse effects while maintaining efficacy. 1

Common Pitfalls to Avoid

  • Nausea and headache are the most common side effects, occurring in 5.6-34% of patients. 1

  • Do not prescribe for perinephric abscess or complicated UTIs—nitrofurantoin is only for uncomplicated lower tract infections. 1

  • For patients with CrCl <60 mL/min, switch to alternative agents such as trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (if local resistance <20%) or fosfomycin trometamol 3 g single dose. 2

Follow-Up Recommendations

  • Routine post-treatment urinalysis or urine cultures are not indicated for asymptomatic patients. 1

  • If symptoms do not resolve by end of treatment or recur within 2 weeks, obtain urine culture with susceptibility testing and consider retreatment with a 7-day regimen using another agent. 1

References

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nitrofurantoin Dosing Considerations in Adults with UTIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017

Research

Nitrofurantoin: what is the evidence for current UK guidance?

The Journal of antimicrobial chemotherapy, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.